We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

133 hedge funds and large institutions have $730M invested in Momenta Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 48 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more call options, than puts

Call options by funds: $17.9M | Put options by funds: $9.68M

39% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 18

23% more capital invested

Capital invested by funds: $591M → $730M (+$139M)

6% more funds holding

Funds holding: 126133 (+7)

19% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 48

Holders
133
Holders Change
+7
Holders Change %
+5.56%
% of All Funds
3.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
25
Increased
39
Reduced
48
Closed
18
Calls
$17.9M
Puts
$9.68M
Net Calls
+$8.22M
Net Calls Change
+$3.47M
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
51
California Public Employees Retirement System
California
$2.07M -$33.5K -1,992 -2%
Allianz Asset Management
52
Allianz Asset Management
Germany
$1.99M
Public Sector Pension Investment Board (PSP Investments)
53
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.98M +$23.5K +1,400 +1%
CS
54
Credit Suisse
Switzerland
$1.91M -$1.84M -109,615 -50%
Prudential Financial
55
Prudential Financial
New Jersey
$1.85M -$10.1K -600 -0.6%
Arrowstreet Capital
56
Arrowstreet Capital
Massachusetts
$1.84M +$626K +37,227 +56%
BlackRock
57
BlackRock
New York
$1.74M +$1.63M +97,000 +6,462%
MCM
58
Matarin Capital Management
New York
$1.73M +$548K +32,621 +50%
AC
59
Ascend Capital
California
$1.72M -$2.47M -146,888 -60%
WC
60
Wexford Capital
Florida
$1.55M -$2.78M -165,250 -65%
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$1.51M +$6.72K +400 +0.5%
Deutsche Bank
62
Deutsche Bank
Germany
$1.26M -$1.71M -101,559 -59%
TC
63
TFS Capital
Pennsylvania
$1.23M +$303K +18,029 +35%
Susquehanna International Group
64
Susquehanna International Group
Pennsylvania
$1.19M +$582K +34,655 +107%
TA
65
Teachers Advisors
New York
$1.18M +$40.7K +2,420 +4%
NCCM
66
Nine Chapters Capital Management
New Jersey
$1.12M +$250K +14,900 +31%
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
$1.01M -$21.5K -1,280 -2%
NG
68
NatWest Group
United Kingdom
$998K +$201K +11,973 +27%
State Board of Administration of Florida Retirement System
69
State Board of Administration of Florida Retirement System
Florida
$944K
SIM
70
Spark Investment Management
New York
$924K +$879K +52,300 New
Macquarie Group
71
Macquarie Group
Australia
$884K
ARTA
72
A.R.T. Advisors
New York
$862K +$516K +30,680 +169%
TPSF
73
Texas Permanent School Fund
Texas
$856K -$5.02K -299 -0.6%
State of Tennessee, Department of Treasury
74
State of Tennessee, Department of Treasury
Tennessee
$856K
Comerica Bank
75
Comerica Bank
Texas
$846K -$22.3K -1,328 -3%

MNTA Hedge Fund Activity: Q4 2013 in Review

133 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2013, worth a combined $730M — up 23% from $591M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new MNTA positions and 18 closed out — a net gain of 7 holders — while 39 added to existing stakes and 48 trimmed.

The largest buyer was Visium Asset Management, adding an estimated $47.4M. The largest seller was Bridger Management, exiting entirely with an estimated $24M sold.

  • 133 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2013, up from 126 in Q3 2013.
  • Funds reported $730M of Momenta Pharmaceuticals, Inc. stock for Q4 2013, up 23% quarter-over-quarter.
  • 25 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2013 and 18 closed out, a net change of +7 holders.
  • The largest Momenta Pharmaceuticals, Inc. buyer in Q4 2013 was Visium Asset Management, an estimated $47.4M added.
  • The largest Momenta Pharmaceuticals, Inc. seller in Q4 2013 was Bridger Management, an estimated $24M sold.

Based on aggregated 13F filings for Q4 2013.